Table 2 Progression of steatosis and demographic and clinical variables in the first evaluation
Variable | Classification | Progression of steatosis | p* | |
|---|---|---|---|---|
Favorable (n = 221) | Unfavorable (n = 58) | |||
Age (years)** | 46.5 ± 8.0 | 48.1 ± 7.8 | 0.180 | |
Sex | Male | 167 (74.9) | 56 (25.1) | |
Female | 54 (96.4) | 2 (3.6) | < 0.001 | |
Weight (kg) | 78.8 ± 13.5 | 92.9 ± 15.1 | < 0.001 | |
BMI (kg/m2)*** | 26.5 ± 3.5 | 30.3 ± 4.3 | < 0.001 | |
AC (cm)β | 92.6 ± 10.6 | 105.4 ± 10.9 | < 0.001 | |
E1#-Physical activity (%) | 155 (83.8) | 30 (16.2) | 0.011 | |
E1#-SAHα (%) | 26 (56.5) | 20 (43.5) | < 0.001 | |
E1#-Diabetes mellitus (%) | 5 (45.5) | 6 (54.6) | 0.013 | |
E1#-Alcohol consumption (%) | 184 (78.6) | 50 (21.4) | 0.820 | |
E1#-Current smoking (%) | 12 (66.7) | 6 (33.3) | 0.228 | |
E1#-Acute myocardial infarction (%) | 1 (100) | 0 (0) | 1 | |
E1#-Stroke (%) | 2 (100) | 0 (0) | 1 | |
E1#-Dyslipidemia (%) | 75 (67) | 37 (33) | < 0.001 | |
Total cholesterol (mg/ dL) | 187.8 ± 34.3 | 189.8 ± 53.2 | 0.795 | |
Triglycerides (mg/ dL) | 117.1 ± 53.6 | 181.8 ± 96.4 | < 0.001 | |
HDL cholesterol (mg/ dL) | 51.7 ± 12.5 | 41.6 ± 11.2 | < 0.001 | |
LDL cholesterol (mg/ dL) | 113.3 ± 33.4 | 113 ± 46.8 | 0.967 | |
NON-HDL cholesterol (mg/ dL) | 134.8 ± 33.9 | 150 ± 55.7 | 0.074 | |
Gamma-GT (U/ L) | 31.3 ± 28.1 | 41.7 ± 48.8 | 0.143 | |
Glucose (mg/dL) | 91.3 ± 10.9 | 97.5 ± 14.9 | 0.004 | |
Glycated hemoglobin (HbA1c%) | 5.5 ± 0.6 | 5.8 ± 0.6 | 0.029 | |
GOT (U/ L) | 21.5 ± 8.0 | 24.4 ± 14.8 | 0.153 | |
GPT (U/ L) | 23.2 ± 10.5 | 34.1 ± 24.8 | 0.002 | |